Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-19-000789

← back to feed
Filed
Aug 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Jun 30, 2019 5.88M sh
Short Term Investments Q2 2019 · Jun 30, 2019 $29.7K
Short Term Investments Q2 2019 · Dec 31, 2018 $28.2K
Current Liabilities Q2 2019 · Jun 30, 2019 $20.94K
Total Liabilities Q2 2019 · Jun 30, 2019 $976.38K
Total Liabilities Q2 2019 · Dec 31, 2018 $955.45K
Current Assets Q2 2019 · Jun 30, 2019 $444.43K
Current Assets Q2 2019 · Dec 31, 2018 $223.42K
Total Assets Q2 2019 · Jun 30, 2019 $4.59M
Total Assets Q2 2019 · Dec 31, 2018 $4.39M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$449.31K
Cash And Equivalents Q2 2019 · Jun 30, 2018 $430.93K
Cash And Equivalents Q2 2019 · Dec 31, 2017 $880.24K
Stockholders Equity Q2 2019 · Jun 30, 2018 $804.8K
Stockholders Equity Q2 2019 · Mar 31, 2018 $1.14M
Stockholders Equity Q2 2019 · Dec 31, 2017 $1.4M
Sga Expense Q2 2019 · Jun 30, 2018 $56.47K
Sga Expense Q2 2019 · Jun 30, 2018 $130.48K
Rd Expense Q2 2019 · Jun 30, 2018 $153.96K
Rd Expense Q2 2019 · Jun 30, 2018 $260.24K
Net Income Q2 2019 · Jun 30, 2018 −$358.04K
Net Income Q2 2019 · Mar 31, 2018 −$290.07K
Operating Income Q2 2019 · Jun 30, 2018 −$272.57K
Operating Income Q2 2019 · Jun 30, 2018 −$515.01K